244 related articles for article (PubMed ID: 29991691)
1. Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers.
Polo A; Marchese S; De Petro G; Montella M; Ciliberto G; Budillon A; Costantini S
Sci Rep; 2018 Jul; 8(1):10395. PubMed ID: 29991691
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
Catto JW; Alcaraz A; Bjartell AS; De Vere White R; Evans CP; Fussel S; Hamdy FC; Kallioniemi O; Mengual L; Schlomm T; Visakorpi T
Eur Urol; 2011 May; 59(5):671-81. PubMed ID: 21296484
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?
Schubert M; Junker K; Heinzelmann J
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1673-95. PubMed ID: 26660324
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as regulators of signal transduction in urological tumors.
Fendler A; Stephan C; Yousef GM; Jung K
Clin Chem; 2011 Jul; 57(7):954-68. PubMed ID: 21632885
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.
Saito Y; Friedman JM; Chihara Y; Egger G; Chuang JC; Liang G
Biochem Biophys Res Commun; 2009 Feb; 379(3):726-31. PubMed ID: 19116145
[TBL] [Abstract][Full Text] [Related]
7. Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools.
Canturk KM; Ozdemir M; Can C; Öner S; Emre R; Aslan H; Cilingir O; Ciftci E; Celayir FM; Aldemir O; Özen M; Artan S
Mol Biol Rep; 2014 Dec; 41(12):8127-35. PubMed ID: 25189652
[TBL] [Abstract][Full Text] [Related]
8. Risk of urinary tract cancers following arsenic exposure and tobacco smoking: a review.
Baghery F; Lau LDW; Mohamadi M; Vazirinejad R; Ahmadi Z; Javedani H; Eslami H; Nazari A
Environ Geochem Health; 2023 Aug; 45(8):5579-5598. PubMed ID: 37248359
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.
Cao Y; Yu SL; Wang Y; Guo GY; Ding Q; An RH
Tumour Biol; 2011 Feb; 32(1):179-88. PubMed ID: 20857258
[TBL] [Abstract][Full Text] [Related]
10. Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence.
Saint-Jacques N; Parker L; Brown P; Dummer TJ
Environ Health; 2014 Jun; 13():44. PubMed ID: 24889821
[TBL] [Abstract][Full Text] [Related]
11. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
12. Exosome-derived microRNAs contribute to prostate cancer chemoresistance.
Li J; Yang X; Guan H; Mizokami A; Keller ET; Xu X; Liu X; Tan J; Hu L; Lu Y; Zhang J
Int J Oncol; 2016 Aug; 49(2):838-46. PubMed ID: 27278879
[TBL] [Abstract][Full Text] [Related]
13. miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA.
Ray J; Haughey C; Hoey C; Jeon J; Murphy R; Dura-Perez L; McCabe N; Downes M; Jain S; Boutros PC; Mills IG; Liu SK
Cancer Lett; 2020 Mar; 473():107-117. PubMed ID: 31874245
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer.
Li A; Zhu X; Wang C; Yang S; Qiao Y; Qiao R; Zhang J
Sci Rep; 2019 Mar; 9(1):5166. PubMed ID: 30914736
[TBL] [Abstract][Full Text] [Related]
15. Gene networks and microRNAs implicated in aggressive prostate cancer.
Wang L; Tang H; Thayanithy V; Subramanian S; Oberg AL; Cunningham JM; Cerhan JR; Steer CJ; Thibodeau SN
Cancer Res; 2009 Dec; 69(24):9490-7. PubMed ID: 19996289
[TBL] [Abstract][Full Text] [Related]
16. Immortalized human urothelial cells as a model of arsenic-induced bladder cancer.
Eblin KE; Bredfeldt TG; Gandolfi AJ
Toxicology; 2008 Jun; 248(2-3):67-76. PubMed ID: 18456381
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
Cao J; Li J; Yang X; Li P; Yao Z; Han D; Ying L; Wang L; Tian J
Sci Rep; 2021 Jan; 11(1):641. PubMed ID: 33436826
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinicopathological significance of glucocorticoid receptor, SGK1, and NDRG1 in hormone-naïve prostate carcinoma.
Hata S; Shimada H; Sato N; Koshiishi M; Ise K; Ogata T; Yamashita S; Ito A; Sasano H; Nakamura Y
Med Mol Morphol; 2022 Dec; 55(4):283-291. PubMed ID: 35861941
[TBL] [Abstract][Full Text] [Related]
19. mRNA-miRNA bipartite networks reconstruction in different tissues of bladder cancer based on gene co-expression network analysis.
Abedi Z; MotieGhader H; Hosseini SS; Sheikh Beig Goharrizi MA; Masoudi-Nejad A
Sci Rep; 2022 Apr; 12(1):5885. PubMed ID: 35393513
[TBL] [Abstract][Full Text] [Related]
20. NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.
Nakshatri H; Appaiah HN; Anjanappa M; Gilley D; Tanaka H; Badve S; Crooks PA; Mathews W; Sweeney C; Bhat-Nakshatri P
Cell Death Dis; 2015 Jan; 6(1):e1608. PubMed ID: 25611383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
